BAL PHARMA
Back to Income Statement
|
BAL PHARMA Last 5 Year Profit After Tax History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹7.24 Cr | ₹7.45 Cr | ₹2.62 Cr | ₹5.71 Cr | ₹4.71 Cr |
What is the latest Profit After Tax of BAL PHARMA ?
| Year | Profit After Tax |
|---|---|
| Mar2026 | ₹7.24 Cr |
| Mar2025 | ₹7.45 Cr |
| Mar2024 | ₹2.62 Cr |
| Mar2023 | ₹5.71 Cr |
| Mar2022 | ₹4.71 Cr |
How is Profit After Tax of BAL PHARMA Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹7.24 Cr | -2.81 | |
| Mar2025 | ₹7.45 Cr | 184.31 | |
| Mar2024 | ₹2.62 Cr | -54.09 | |
| Mar2023 | ₹5.71 Cr | 21.07 | |
| Mar2022 | ₹4.71 Cr | - | |
Compare Profit After Tax of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹166.6 Cr | 4.5% | 21.2% | 21.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,597.0 Cr | 1% | -3.3% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,195.0 Cr | 2.6% | 10.8% | 57.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,712.0 Cr | 2.7% | 0.3% | 39.6% | Stock Analytics | |
| CIPLA | ₹113,423.0 Cr | 2.4% | -1.1% | -12.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,195.0 Cr | 2.5% | 0.8% | -8.5% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | 4.5% |
21.2% |
21.3% |
| SENSEX | -1% |
-4.9% |
-11% |
You may also like the below Video Courses